These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8750895)

  • 1. Regulation of neurotensin receptor mRNA expression by the receptor antagonist SR 48692 in the rat midbrain dopaminergic neurons.
    Yamada M; Bolden-Watson C; Watson MA; Cho T; Coleman NJ; Yamada M; Richelson E
    Brain Res Mol Brain Res; 1995 Nov; 33(2):343-6. PubMed ID: 8750895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correspondence between high affinity 125I-neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: a combined radioautographic and immunohistochemical light microscopic study.
    Szigethy E; Beaudet A
    J Comp Neurol; 1989 Jan; 279(1):128-37. PubMed ID: 2563267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors.
    Nouel D; Faure MP; St Pierre JA; Alonso R; Quirion R; Beaudet A
    J Neurosci; 1997 Mar; 17(5):1795-803. PubMed ID: 9030638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.
    Yamada M; Yamada M; Richelson E
    Neuroscience; 1995 Jan; 64(2):405-17. PubMed ID: 7700529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692.
    Azzi M; Nicot A; Gully D; Kitabgi P; Bérod A; Rostène W
    Neurosci Lett; 1994 May; 172(1-2):97-100. PubMed ID: 8084546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological substrate for neurotensin-dopamine interactions in the rat midbrain tegmentum.
    Beaudet A; Woulfe J
    Ann N Y Acad Sci; 1992; 668():173-85. PubMed ID: 1361112
    [No Abstract]   [Full Text] [Related]  

  • 7. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
    Steinberg R; Brun P; Fournier M; Souilhac J; Rodier D; Mons G; Terranova JP; Le Fur G; Soubrié P
    Neuroscience; 1994 Apr; 59(4):921-9. PubMed ID: 8058127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
    Azzi M; Betancur C; Sillaber I; Spanagel R; Rostène W; Bérod A
    J Neurochem; 1998 Sep; 71(3):1158-67. PubMed ID: 9721741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin terminals form synapses primarily with neurons lacking detectable tyrosine hydroxylase immunoreactivity in the rat substantia nigra and ventral tegmental area.
    Woulfe J; Beaudet A
    J Comp Neurol; 1992 Jul; 321(1):163-76. PubMed ID: 1351897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system.
    Steinberg R; Bougault I; Souilhac J; Gully D; Le Fur G; Soubrié P
    Neurosci Lett; 1994 Jan; 166(1):106-8. PubMed ID: 7514773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of neurotensin receptor mRNA in the dopaminergic cell groups of the rat diencephalon and mesencephalon.
    Nicot A; Rostène W; Bérod A
    J Neurosci Res; 1995 Apr; 40(5):667-74. PubMed ID: 7602617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical evidence for direct connections between neurotensin-containing axons and dopaminergic neurons in the rat ventral midbrain tegmentum.
    Woulfe J; Beaudet A
    Brain Res; 1989 Feb; 479(2):402-6. PubMed ID: 2564307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro.
    Pinnock RD; Woodruff GN
    Neurosci Lett; 1994 May; 172(1-2):175-8. PubMed ID: 8084529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
    Weiss-Wunder LT; Chesselet MF
    Neuroscience; 1992 Jul; 49(2):297-305. PubMed ID: 1359452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
    Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
    J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
    Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture.
    Antonelli T; Tomasini MC; Finetti S; Giardino L; Calzà L; Fuxe K; Soubriè P; Tanganelli S; Ferraro L
    J Neurosci Res; 2002 Dec; 70(6):766-73. PubMed ID: 12444598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
    Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
    Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons.
    Azam L; Winzer-Serhan UH; Chen Y; Leslie FM
    J Comp Neurol; 2002 Mar; 444(3):260-74. PubMed ID: 11840479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.